| [1] |
Bolton-Maggs PH, Davies T, Poles D, et al. Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme[J]．Int J Obstet Gynaecol, 2013，120(7):873-878.
|
| [2] |
Abdel-Fattah SA, Soothill PW, Carroll SG, et al. Middle cerebral artery Doppler for the prediction of fetal anaemia in cases without hydrops: a practical approach[J]. Br J Radiol, 2002, 75(897):726-730.
|
| [3] |
Daniels G. Variants of RhD--current testing and clinical consequences[J]. Br J Haematol, 2013, 16(14):461-470.
|
| [4] |
田兆嵩. 临床输血学[M]. 2版. 北京：人民卫生出版社，2002: 178.
|
| [5] |
Bowman JM. Controversies in Rhprophylaxis: who needs Rhimmune globulin and when should it be given？[J]. Am J Obstet Gynecol, 1985, 151(3):289-294.
|
| [6] |
Bowman J. Rh-immunoglobulin: Rhprophylaxis[J]. Best Pract Res Clin Haemato, 2006, 19(1):27-34.
|
| [7] |
American College Obstetricians, Gynecologists, American Academy of Pediatrics. Guidelines for Perinatal Care[M]. 7th ed. Washington: Amer Academy of Pediatrics, 2012：164-167.
|
| [8] |
Tynan JA, Angkachatchai V, EhrichM, et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing[J]. Am J Obstet Gynecol, 2011, 204(3):251.e1-e6.
|
| [9] |
Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses[J]. N Engl J Med, 2000, 342(1):9-14.
|
| [10] |
Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia[J]. N Engl J Med, 2006, 355(2):156-164.
|
| [11] |
Zipursky A, Paul VK. The global burden of Rh disease[J]．Arch Dis Child Fetal Neonatal Ed, 2011, 96(2):F84-F85.
|
| [12] |
Coopamah MD, Freeman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist[J]. Blood, 2003, 102(8):2862-2867.
|
| [13] |
Boruchov AM, Heller G, Veri MC, et al. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions[J]. J Clin Invest, 2005, 115(10):2914-2923.
|
| [14] |
Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis)[J]. Immunology Letters, 2002, 82(1-2):67-73.
|
| [15] |
Daniels G. Variants of RhD--current testing and clinical consequences[J]. Br J Haematol, 2013, 161(4):461-470.
|
| [16] |
Cunningham FG, Leveno KJ, Bloom SL, et al. Williams obstetrics[M]. 24th ed. New York: McGraw-Hill Education, 2014：312.
|
| [17] |
Chambers E, Davies L, Evans S, et al. Comparison of haemoglobin F detection by the acidelution test, flow cytometry and high-performance liquidchromatography in maternal blood samples analysed for fetomaternal haemorrhage[J]. Transfus Med, 2012, 22(3):199-204.
|
| [18] |
Chilcott J, Lloyd JM, Wight J, et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative[J]. Health Technol Assess, 2003, 7(4):iii-62.
|
| [19] |
Kent J, Farrell AM, Soothill P. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice[J]. BMC Pregnancy Childbirth, 2014, 14:87.
|
| [20] |
Fox C, Martin W, Somerset DA, et al. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion[J]. Fetal Diagn Ther, 2008, 23(2):159-163.
|
| [21] |
Scheier M, Hernandez-Andrade E, Fonseca EB, et al. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusion[J]. Am J Obstet Gynecol, 2006，195 (6):1550-1556.
|
| [22] |
van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetalanemia due to maternalred-cellalloimmunization[J]. Am J Obstet Gynecol, 2005, 192(1):171-177.
|
| [23] |
Lindenburg IT, van Kamp IL, van Zwet EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation[J]. BJOG, 2013, 120(7):847-852.
|
| [24] |
Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmentaloutcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study[J]. Am J Obstet Gynecol, 2012, 206(2):141.e1-e8.
|